USEUROPEAFRICAASIA 中文双语Français
Home / Business

Merck Sharp & Dohme Corp to augment HPV vaccine supplies to China

By Liu Zhihua | China Daily | Updated: 2019-07-01 08:00

The supply of much-sought-after human papillomavirus or HPV vaccine to China will be "remarkably "increased within this year to meet unfulfilled demand in the Chinese market, executives of Merck Sharp& Dohme Corp, a US-based pharmaceutical company, said.

The firm is known as Merck& Co Inc in the United States and Canada. Merck has been proactively cooperating with "internal and external partners", and has adopted a range of strategies to increase HPV vaccine supplies.

It will leverage its global distribution network and expanding production to serve the Chinese market better, according to its China branch.

Merck Sharp & Dohme Corp to augment HPV vaccine supplies to China

Today's Top News

Editor's picks

Most Viewed

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US